Prevention of osteoporosis with other than HRT-bisphosphonates

被引：0

作者：

Liberman, UA ^{[1
]}

机构：

[1] Tel Aviv Univ, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel

来源：

FIRST WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY | 1999年

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：39 / 39

页数：1

共 50 条

[31] Tolerability of oral bisphosphonates in patients with osteoporosis and other osteopathies
Spivacow, R
Roldan, EJA
Zanetti, D
Piccinni, E
Zanchetta, JR
MEDICINA-BUENOS AIRES, 1997, 57 : 114 - 118
[32] OSTEOPOROSIS AND HRT
MILNER, M
HARRISON, RF
IRISH MEDICAL JOURNAL, 1991, 84 (01) : 2 - 3
[33] HRT AND OSTEOPOROSIS
BARLOW, DH
BAILLIERES CLINICAL RHEUMATOLOGY, 1993, 7 (03): : 535 - 548
[34] Justification for the use of HRT in the long-term prevention of osteoporosis
Stevenson, JC
MATURITAS, 2005, 51 (02) : 113 - 126
[35] HRT AND OSTEOPOROSIS
COMPSTON, JE
BRITISH MEDICAL BULLETIN, 1992, 48 (02) : 309 - 344
[36] Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?
Philip N Sambrook
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 206 - 207
[37] HRT AND FRACTURE PREVENTION: MORE THAN JUST BONE
Stevenson, J. C.
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S77 - S77
[38] Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?
Sambrook, Philip N.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (03): : 206 - 207
[39] Drug Insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men
Sue A Brown
Theresa A Guise
Nature Clinical Practice Urology, 2007, 4 : 310 - 320
[40] Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men
Brown, Sue A.
Guise, Theresa A.
NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (06): : 310 - 320

← 1 2 3 4 5 →